Sorafenib Tosylate

Category API

Details	Specifications
CAS Number	475207-59-1
Molecular Formula	C28H24ClF3N4O6S
Molecular Weight	637.03 g/mol.
Synonyms	4-[4-[[4-chloro-3-(trifluoromethyl) phenyl] carbamoyl amino] phenoxy]-N-methylpyridine-2-carboxamide;4-methylbenzenesulfonic acid
Chemical Name	4-[4-[[4-chloro-3-(trifluoromethyl) phenyl] carbamoyl amino] phenoxy]-N-methylpyridine-2-carboxamide;4-methyl benzene sulfonic acid
Common name	Sorafenib
Therapeutic use	Sorafenib is a kinase inhibitor used to treat unresectable liver carcinoma, advanced renal carcinoma, and differentiated thyroid carcinoma
Background	Sorafenib tosylate (marketed as [Nexavar](https://www.drugs.com/pro/sorafenib.html) by Bayer) is a potent, oral multikinase inhibitor primarily used as a targeted therapy for advanced cancers. It was first approved by the FDA in 2005 for advanced renal cell carcinoma, later gaining approvals for hepatocellular carcinoma (liver cancer) and differentiated thyroid carcinoma.
Grade	In-house
Polymorph	Form-III
GTI	Risk assessment report available
Nitrosamines	Risk assessment report available
DMF Availability	CEP 2022 - 056 - Rev 01
Manufacturing batch size	15.0 Kg
Production capacity	Annual capacity is 1.0 - 1.2 tonnes
Stability data	Available

Please Note: We partner exclusively with pharmaceutical manufacturers, biotech companies, and international trading firms. Minimum order quantities apply*

Disclaimer:

The information provided on this webpage is based on the best available knowledge at the time of publication; however, accuracy and completeness are not guaranteed. Product specifications may change without notice. It is the responsibility of the purchaser or user to verify suitability and compliance. This product is intended for research use only and is not approved for human consumption.

Why Shilpa Pharma?

Happy Customers

Projects Successfully Completed

Established

PhD Experts Driving R&D Excellence

Team Size

World-Class API Manufacturing Sites

Global Audits Successfully Completed

Comprehensive CDMO Service Offerings

Our Sorafenib Tosylate are also Available for

Questions & Answers

FAQ on Sorafenib Tosylate

Everything You Need to Know About Shilpa Pharma

Shilpa Pharma – Your Trusted Global CDMO Partner

Delivering end-to-end solutions across API oncology, generics, peptides, polymers and specialty chemicals, we empower partners to accelerate development, ensure compliance, and reach markets faster with reliable, cost-effective innovation.